GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Medifast Inc (LTS:0K05) » Definitions » EV-to-FCF

Medifast (LTS:0K05) EV-to-FCF : 0.55 (As of Mar. 05, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Medifast EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Medifast's Enterprise Value is $9.4 Mil. Medifast's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 was $17.0 Mil. Therefore, Medifast's EV-to-FCF for today is 0.55.

The historical rank and industry rank for Medifast's EV-to-FCF or its related term are showing as below:

LTS:0K05' s EV-to-FCF Range Over the Past 10 Years
Min: 0.55   Med: 16.54   Max: 52.61
Current: 0.55

During the past 13 years, the highest EV-to-FCF of Medifast was 52.61. The lowest was 0.55. And the median was 16.54.

LTS:0K05's EV-to-FCF is ranked better than
92.31% of 78 companies
in the Personal Services industry
Industry Median: 18.475 vs LTS:0K05: 0.55

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-05), Medifast's stock price is $13.824. Medifast's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $0.180. Therefore, Medifast's PE Ratio (TTM) for today is 76.80.


Medifast EV-to-FCF Historical Data

The historical data trend for Medifast's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medifast EV-to-FCF Chart

Medifast Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.42 38.96 6.70 4.28 2.73

Medifast Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.28 3.35 1.73 1.69 2.73

Competitive Comparison of Medifast's EV-to-FCF

For the Personal Services subindustry, Medifast's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medifast's EV-to-FCF Distribution in the Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Medifast's EV-to-FCF falls into.



Medifast EV-to-FCF Calculation

Medifast's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=9.426/17.022
=0.55

Medifast's current Enterprise Value is $9.4 Mil.
Medifast's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $17.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medifast  (LTS:0K05) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Medifast's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13.824/0.180
=76.80

Medifast's share price for today is $13.824.
Medifast's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.180.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Medifast EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Medifast's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Medifast Business Description

Traded in Other Exchanges
Address
100 International Drive, Baltimore, MD, USA, 21202
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Medifast Headlines

No Headlines